Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 Generic Hyzaar and Cozaar Approved by FDA | Contract Pharma

What are you searching for?

Sign in
Breaking News, Trials & Filings

Generic Hyzaar and Cozaar Approved by FDA

Mylan Pharmaceuticals, Inc. received approval from the FDA for its ANDAs for the generic versions of antihypertensive drugs Hyzaar Tablets, 50 mg/12.5 mg and 100 mg/25 mg, and Cozaar Tablets, 25 mg, 50 mg and 100 mg.

Author Image

By: Tim Wright

Editor-in-Chief, Contract Pharma

Mylan Pharmaceuticals, Inc. received approval from the FDA for its ANDAs for the generic versions of antihypertensive drugs Hyzaar Tablets, 50 mg/12.5 mg and 100 mg/25 mg, and Cozaar Tablets, 25 mg, 50 mg and 100 mg. Merck’s Hyzaar and Cozaar are known generically as Losartan Potassium and Hydrochlorothiazide (HCTZ) Tablets, and Losartan Potassium Tablets, respectively.

According to IMS Health, the two drugs had U.S. sales of approximately $1.5 billion for the 12 months ending June 30, 2010. Both products are available for immediate shipment. Mylan launched the 100 mg/12.5 mg strength of Losartan Potassium and HCTZ Tablets on April 6, 2010.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters